medigraphic.com
Órgano Oficial del Instituto de Ciencias de la Salud, Hospital Escuela y Facultad de Medicina-Xalapa

2018, Number 2

<< Back Next >>

Rev Med UV 2018; 18 (2)

Study of the first case carried out in the state of Veracruz

Zaballa CJF, Escutia CHH, Merino RJA, Morales PJD, Muratalla GR, García GF, Fernández CE, González AF, Guzmán GH, Baca EG, Espinoza RMA

Language: Spanish
References: 19
Page: 25-40
PDF size: 649.74 Kb.


ABSTRACT

Aortic valve stenosis is the most common valvulopathy worldwide, as well as in Mexico. The prognosis with medical treatment is unfavorable in the medium and long term, the treatment for more than 50 years has been the surgical valve replacement, and almost a third of the patients were considered at high risk and considered out of management. Since 2012, percutaneous valvular implantation in Mexico has been performed, thus providing a new therapeutic alternative to our patients increasingly established within the cardiological field of our country. Here we present the case of a 74 year-old female with severe aortic stenosis and high surgical risk treated with percutaneous valve implantation, with an adequate clinical outcome. This is the first case treated with this new alternative in the state of Veracruz, Mexico.


REFERENCES

  1. Adams, D., Popma, J., Reardon, M., Yakubov, S., Coselli, J., Deeb, G., et al. (2014). Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis. N Engl J Med, 370(1790), 8.

  2. Cervantes, J. (2002). 50 Aniversario de la implantación de la primera válvula aórtica. Arch Cardiol Mex, 72(187), 91.

  3. Cribier, A., Eltchaninoff, H., Bash, A., Borenstein, N., Tron, C., Bauer, F., et al. (2002). Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description. Circulation, 106(3006), 8.

  4. Cribier, A. (2014). The Odyssey of TAVR from Concept to Clinical Reality. Texas H Institute Journal, 41(125), 30.

  5. Dobson, L., Musa, A., Fairbairn, T., Uddin, A., Blackman, D., Ripley, D., et al. (2015). CMR Assessment of Longitudinal Left Ventricular Function Following Transcatheter Aortic Valve Implantation (TAVI) for Severe Aortic Stenosis. Journal of Cardiovascular Magnetic Resonance, 17(Suppl 1), 180.

  6. Edwards, J. (1961). Calcific Aortic Stenosis: Pathologic Features. Proc Staff Mett Mayo Clin, 36(441), 51.

  7. Gilard, M., Eltchaninoff, H., Lung, B., Donzeau-Gouge, P., Chevreul, K., Fajadet, J., et al. (2012). FRANCE 2 Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients. N Engl J Med, 366(1705), 15.

  8. Grube, E., Schuler, G., Buellesfeld, L., Gerckens, U., Linke, A., Wenaweser, P., et al. (2007). Percutaneous Aortic Valve Replacement for Severe Aortic Stenosis in High-Risk Patients Using the Second- and Current Third-Generation SelfEexpanding CoreValve Prosthesis: Device Success and 30-Day Clinical Outcome. J Am Coll Cardiol, 50(69), 76.

  9. Hamm C., Möllmann, H., Holzhey, D., Beckmann, A., Veit, C., Figulla, H., et al. (2014). The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J, 35(1588), 98.

  10. Leon, M., Smith, C., Mack, M., Miller, D., Moses, J., Svensson, L., et al. (2010). Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med, 363(1597), 607.

  11. Leon, M., Smith, C., Mack, M., Makkar, R., Svensson, L., Kodali, S., et al. (2016). Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med, 374(1609), 20.

  12. Linke, A., Wenaweser, P., Gerckens, U., Tamburino, C., Bosmans, J., Bleiziffer, S., et al. (2014). Treatment of Aortic Stenosis with a Self-Expanding Transcatheter Valve: The International Multi-Centre ADVANCE Study. Eur Heart J, 35(2672), 84.

  13. López-Aguilera, J., Segura, J., Mazuelos, F., Suárez de Lezo, S., Ojeda, S., Álvarez- Ossorio, M., et al. (2016). Modificación de la conducción auriculoventricular tras el implante de prótesis aórtica CoreValve. Rev Esp Cardiol, 69(28), 36.

  14. Lung, B., Baron, G., Butchart, E., Delahaye, F., Gohlke-Barwolf, C., Levang, O. (2003). A Prospective Survey of Patients with Valvular Heart Disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J, 24(1231), 43. Lung, B., Cachier, A., Baron, G., Messika-Zeitoun, D., Delahaye, F., Tornos, P., et al. (2005). Decision-Making in Elderly Patients with Severe Aortic Stenosis: Why are so Many Denied Surgery? Eur Heart J, 26(2714), 20.

  15. Moat, N., Ludman, P., De Belder, M., Bridgewater, B., Cunningham, A., Young, C., et al. (2011). Long-Term Outcomes after Transcatheter Aortic Valve Implantation in High-Risk Patients with Severe Aortic Stenosis: the UK TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol, 58(2130), 8.

  16. Muñoz-García, A., Del Valle, R., Trillo-Nouche, R., Elízaga, J., Gimeno, F., Hernández-Antolín, R., et al. (2013). The Ibero-American Transcatheter Aortic Valve Implantation Registry with the CoreValve Prosthesis. Early and Long-Term Results. Int J Cardiol, 169(359), 65.

  17. Nkomo, V., Gardin, J., Skelton, T., Gottdiener, J., Scott, C., Enriquez-Sarano, M. (2006). Burden of Valvular Heart Diseases: A Population-Based Study. Lancet, 368(1005), 11.

  18. Piazza, N., Grube, E., Gerckens, U., Den Heijer, P., Linke, A., Luha, O., et al. (2008). Procedural and 30-Day Outcomes Following Transcatheter Aortic Valve Implantation Using the Third Generation (18F) CoreValve Revalving System: Results from the Multicentre, Expanded Evaluation Registry 1-Year Following CE Mark Approval. EuroIntervention, 4(242), 9.

  19. Roberts, W. (1970). Anatomically Isolated Aortic Valvular Disease: The Case Against its Being of Rheumatic Etiology. Am J Med, 49(151), 9.




2020     |     www.medigraphic.com